Fifth Third Bancorp Novo Cure LTD Transaction History
Fifth Third Bancorp
- $25.9 Billion
- Q1 2025
A detailed history of Fifth Third Bancorp transactions in Novo Cure LTD stock. As of the latest transaction made, Fifth Third Bancorp holds 2,500 shares of NVCR stock, worth $46,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$46,250
Previous $74,000
40.54%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding NVCR
# of Institutions
296Shares Held
75.8MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$224 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$218 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$164 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$89.1 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$50.7 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.94B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...